NKGen Biotech (NKGN) announced the oral presentation of updated Phase 1 clinical data from the Phase 1/2a trial evaluating troculeucel, ...

BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.

Medically reviewed by Huma Sheikh, MDThe Montreal Cognitive Assessment (MoCA) is a commonly used test to detect mild cognitive decline and early signs of dementia. It can help identify people at risk ...